LTGO vs BLMN
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
LTGO · Latigo Biotherapeutics$12.60 ▼ 3.15%
BLMN · Bloomin Brands$9.75 ▼ 6.88%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- LTGO -31.0%
- BLMN -11.0%
Head to head
| Metric | LTGO | BLMN |
|---|---|---|
| Price | $12.60 | $9.75 |
| Change today | ▼ 3.15% | ▼ 6.88% |
| Market cap | $835.37M | $834.80M |
| Return, 3 months | -32.1% | -11.5% |
| Return, year to date | – | +58.0% |
| Return, 1 year | – | +46.0% |
| P/E (TTM) | – | 11.7 |
| P/B | 2.1 | 1.9 |
| P/E percentile vs own 5y | 94th | 86th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +1.3% |
| Net profit growth (YoY) | +0.1% | +22.2% |
| Gross margin | – | 13.4% |
| Operating margin | – | 3.2% |
| Net margin | – | 0.7% |
| Return on equity | – | 6.7% |
| Analyst target vs. price | +357.7% | +19.8% |
| Analyst buy share | 100% | 0% |
| RSI (14) | 35 | 50 |
| 30-day volatility | 87.3% | 73.3% |
| Max drawdown, 1 year | -49.6% | -34.8% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- LTGO is the largest of the group by market value.
- BLMN has been the calmest stock over the last 30 days.